Статті в журналах з теми "Vaccine candidate protein"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся з топ-50 статей у журналах для дослідження на тему "Vaccine candidate protein".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Переглядайте статті в журналах для різних дисциплін та оформлюйте правильно вашу бібліографію.
Panda, Chinmaya, and Rajani Kanta Mahapatra. "Identification of novel therapeutic candidates inCryptosporidium parvum: anin silicoapproach." Parasitology 145, no. 14 (April 25, 2018): 1907–16. http://dx.doi.org/10.1017/s0031182018000677.
Повний текст джерелаZeb, Samia, Amjad Ali, Sardar Muhammad Gulfam, and Habib Bokhari. "Preliminary Work Towards Finding Proteins as Potential Vaccine Candidates for Vibrio cholerae Pakistani Isolates through Reverse Vaccinology." Medicina 55, no. 5 (May 23, 2019): 195. http://dx.doi.org/10.3390/medicina55050195.
Повний текст джерелаTumban, Ebenezer. "Lead SARS-CoV-2 Candidate Vaccines: Expectations from Phase III Trials and Recommendations Post-Vaccine Approval." Viruses 13, no. 1 (December 31, 2020): 54. http://dx.doi.org/10.3390/v13010054.
Повний текст джерелаMayers, Carl, Melanie Duffield, Sonya Rowe, Julie Miller, Bryan Lingard, Sarah Hayward, and Richard W. Titball. "Analysis of Known Bacterial Protein Vaccine Antigens Reveals Biased Physical Properties and Amino Acid Composition." Comparative and Functional Genomics 4, no. 5 (2003): 468–78. http://dx.doi.org/10.1002/cfg.319.
Повний текст джерелаGarcía-Basteiro, Alberto L., Quique Bassat, and Pedro L. Alonso. "APPROACHING THE TARGET: THE PATH TOWARDS AN EFFECTIVE MALARIA VACCINE." Mediterranean Journal of Hematology and Infectious Diseases 4, no. 1 (March 10, 2012): e2012015. http://dx.doi.org/10.4084/mjhid.2012.015.
Повний текст джерелаvan Doremalen, Neeltje, Robert J. Fischer, Jonathan E. Schulz, Myndi G. Holbrook, Brian J. Smith, Jamie Lovaglio, Benjamin Petsch, and Vincent J. Munster. "Immunogenicity of Low-Dose Prime-Boost Vaccination of mRNA Vaccine CV07050101 in Non-Human Primates." Viruses 13, no. 8 (August 19, 2021): 1645. http://dx.doi.org/10.3390/v13081645.
Повний текст джерелаLoo, Ke-Yan, Vengadesh Letchumanan, Hooi-Leng Ser, Siew Li Teoh, Jodi Woan-Fei Law, Loh Teng-Hern Tan, Nurul-Syakima Ab Mutalib, Kok-Gan Chan, and Learn-Han Lee. "COVID-19: Insights into Potential Vaccines." Microorganisms 9, no. 3 (March 15, 2021): 605. http://dx.doi.org/10.3390/microorganisms9030605.
Повний текст джерелаWainwright, Eleanor, and Rebecca K. Shears. "Trichuris WAP and CAP proteins: Potential whipworm vaccine candidates?" PLOS Neglected Tropical Diseases 16, no. 12 (December 22, 2022): e0010933. http://dx.doi.org/10.1371/journal.pntd.0010933.
Повний текст джерелаSchautteet, Katelijn, Edith Stuyven, Eric Cox, and Daisy Vanrompay. "Validation of the Chlamydia trachomatis genital challenge pig model for testing recombinant protein vaccines." Journal of Medical Microbiology 60, no. 1 (January 1, 2011): 117–27. http://dx.doi.org/10.1099/jmm.0.024448-0.
Повний текст джерелаWattimena, Mauritz Nicolaas, and Wijanarka Wijanarka. "In Silico Analysis Prediction of B-Cell Epitope as a Vaccine Candidate for SARS-CoV-2 B.1.617.2 (Delta) Variant." Journal of Biomedicine and Translational Research 1, no. 1 (March 8, 2022): 7–15. http://dx.doi.org/10.14710/jbtr.v1i1.13113.
Повний текст джерелаHong, So-Hee, Hanseul Oh, Yong Wook Park, Hye Won Kwak, Eun Young Oh, Hyo-Jung Park, Kyung Won Kang, et al. "Immunization with RBD-P2 and N protects against SARS-CoV-2 in nonhuman primates." Science Advances 7, no. 22 (May 2021): eabg7156. http://dx.doi.org/10.1126/sciadv.abg7156.
Повний текст джерелаMonterrubio-López, Gloria P., Jorge A. González-Y-Merchand, and Rosa María Ribas-Aparicio. "Identification of Novel Potential Vaccine Candidates against Tuberculosis Based on Reverse Vaccinology." BioMed Research International 2015 (2015): 1–16. http://dx.doi.org/10.1155/2015/483150.
Повний текст джерелаBellamkonda, Navya, Upendra Pradeep Lambe, Sonali Sawant, Shyam Sundar Nandi, Chiranjib Chakraborty, and Deepak Shukla. "Immune Response to SARS-CoV-2 Vaccines." Biomedicines 10, no. 7 (June 21, 2022): 1464. http://dx.doi.org/10.3390/biomedicines10071464.
Повний текст джерелаHudson, Laura C., Renu Garg, Kenneth L. Bost, and Kenneth J. Piller. "Soybean Seeds: A Practical Host for the Production of Functional Subunit Vaccines." BioMed Research International 2014 (2014): 1–13. http://dx.doi.org/10.1155/2014/340804.
Повний текст джерелаBrown, Jeremy S., A. David Ogunniyi, Matthew C. Woodrow, David W. Holden, and James C. Paton. "Immunization with Components of Two Iron Uptake ABC Transporters Protects Mice against Systemic Streptococcus pneumoniae Infection." Infection and Immunity 69, no. 11 (November 1, 2001): 6702–6. http://dx.doi.org/10.1128/iai.69.11.6702-6706.2001.
Повний текст джерелаChathuranga, W. A. Gayan, Chamith Hewawaduge, N. A. Nadeeka Nethmini, Tae-Hwan Kim, Ju Hun Kim, Young-Hoon Ahn, In-Joong Yoon, Sung-Sik Yoo, Jong-Hyeon Park, and Jong-Soo Lee. "Efficacy of a Novel Multiepitope Vaccine Candidate against Foot-and-Mouth Disease Virus Serotype O and A." Vaccines 10, no. 12 (December 19, 2022): 2181. http://dx.doi.org/10.3390/vaccines10122181.
Повний текст джерелаWang, Xingyun, Nino Rcheulishvili, Jie Cai, Cong Liu, Fengfei Xie, Xing Hu, Nuo Yang, et al. "Development of DNA Vaccine Candidate against SARS-CoV-2." Viruses 14, no. 5 (May 15, 2022): 1049. http://dx.doi.org/10.3390/v14051049.
Повний текст джерелаAlshammari, Abdulrahman, Abdullah F. Alasmari, Metab Alharbi, Nemat Ali, Ziyad Tariq Muhseen, Usman Ali Ashfaq, Miraj Ud-din, Asad Ullah, Muhammad Arshad, and Sajjad Ahmad. "Novel Chimeric Vaccine Candidate Development against Leptotrichia buccalis." International Journal of Environmental Research and Public Health 19, no. 17 (August 29, 2022): 10742. http://dx.doi.org/10.3390/ijerph191710742.
Повний текст джерелаMatsegora, N. А., and A. V. Kaprosh. "Current state of developments and research of new candidate vaccines against tuberculosis (literature review)." Tuberculosis, Lung Diseases, HIV Infection, no. 2 (June 17, 2022): 48–57. http://dx.doi.org/10.30978/tb-2022-2-48.
Повний текст джерелаRostad, Christina A., Christopher C. Stobart, Brian E. Gilbert, Ray J. Pickles, Anne L. Hotard, Jia Meng, Jorge C. G. Blanco, et al. "A Recombinant Respiratory Syncytial Virus Vaccine Candidate Attenuated by a Low-Fusion F Protein Is Immunogenic and Protective against Challenge in Cotton Rats." Journal of Virology 90, no. 16 (June 8, 2016): 7508–18. http://dx.doi.org/10.1128/jvi.00012-16.
Повний текст джерелаHarland, David N., Karen Chu, Ashraful Haque, Michelle Nelson, Nicola J. Walker, Mitali Sarkar-Tyson, Timothy P. Atkins, et al. "Identification of a LolC Homologue in Burkholderia pseudomallei, a Novel Protective Antigen for Melioidosis." Infection and Immunity 75, no. 8 (May 21, 2007): 4173–80. http://dx.doi.org/10.1128/iai.00404-07.
Повний текст джерелаHuang, Claire Y. H., Siritorn Butrapet, Dennis J. Pierro, Gwong-Jen J. Chang, Ann R. Hunt, Natth Bhamarapravati, Duane J. Gubler, and Richard M. Kinney. "Chimeric Dengue Type 2 (Vaccine Strain PDK-53)/Dengue Type 1 Virus as a Potential Candidate Dengue Type 1 Virus Vaccine." Journal of Virology 74, no. 7 (April 1, 2000): 3020–28. http://dx.doi.org/10.1128/jvi.74.7.3020-3028.2000.
Повний текст джерелаWang, Yan, Kui Zhao, Deguang Song, Le Du, Xinyue Wang, Feng Gao, Huijun Lu, and Jiyu Guan. "Evaluation of the Immune Response Afforded by Combined Immunization with Orf Virus DNA and Subunit Vaccine in Mice." Vaccines 10, no. 9 (September 8, 2022): 1499. http://dx.doi.org/10.3390/vaccines10091499.
Повний текст джерелаEroshkin, Alexey M., Elena A. Karginova, Irina P. Gileva, Alexander S. Lomakin, Leonid R. Lebedev, Tatiana P. Kamyinina, Alexander V. Pereboev, and Georgy M. Ignat'ev. "Design of four-helix bundle protein as a candidate for HIV vaccine." "Protein Engineering, Design and Selection" 8, no. 2 (1995): 167–73. http://dx.doi.org/10.1093/protein/8.2.167.
Повний текст джерелаVõ, Tuấn-Cường, Haung Naw, Rochelle A. Flores, Hương-Giang Lê, Jung-Mi Kang, Won-Gi Yoo, Woo-Hyun Kim, Wongi Min, and Byoung-Kuk Na. "Genetic Diversity of Microneme Protein 2 and Surface Antigen 1 of Eimeria tenella." Genes 12, no. 9 (September 15, 2021): 1418. http://dx.doi.org/10.3390/genes12091418.
Повний текст джерелаNaung, Myo T., Elijah Martin, Jacob Munro, Somya Mehra, Andrew J. Guy, Moses Laman, G. L. Abby Harrison, et al. "Global diversity and balancing selection of 23 leading Plasmodium falciparum candidate vaccine antigens." PLOS Computational Biology 18, no. 2 (February 2, 2022): e1009801. http://dx.doi.org/10.1371/journal.pcbi.1009801.
Повний текст джерелаMurawski, Matthew R., Lori W. McGinnes, Robert W. Finberg, Evelyn A. Kurt-Jones, Michael J. Massare, Gale Smith, Penny M. Heaton, Armando E. Fraire, and Trudy G. Morrison. "Newcastle Disease Virus-Like Particles Containing Respiratory Syncytial Virus G Protein Induced Protection in BALB/c Mice, with No Evidence of Immunopathology." Journal of Virology 84, no. 2 (November 4, 2009): 1110–23. http://dx.doi.org/10.1128/jvi.01709-09.
Повний текст джерелаVenkatesan, Malabi M. "A novel protein‐based subunit Shigella vaccine candidate." Immunology & Cell Biology 93, no. 7 (June 9, 2015): 603–4. http://dx.doi.org/10.1038/icb.2015.56.
Повний текст джерелаBystrický, S. "Candida albicans mannan–protein conjugate as vaccine candidate." Immunology Letters 85, no. 3 (February 3, 2003): 251–55. http://dx.doi.org/10.1016/s0165-2478(02)00241-9.
Повний текст джерелаDavila, Jose, Lixin Zhang, Carl F. Marrs, Riza Durmaz, and Zhenhua Yang. "Assessment of the Genetic Diversity ofMycobacterium tuberculosis esxA, esxH, andfbpBGenes among Clinical Isolates and Its Implication for the Future Immunization by New Tuberculosis Subunit Vaccines Ag85B-ESAT-6 and Ag85B-TB10.4." Journal of Biomedicine and Biotechnology 2010 (2010): 1–6. http://dx.doi.org/10.1155/2010/208371.
Повний текст джерелаOuattara, Amed, Anki Dwivedit, Matthew Adams, Amadou Niangaly, Matthew B. Laurens, Myaing M. Nyunt, Christopher V. Plowe, Abdoulaye Djimde, Shannon Takala-Harrison, and Joana C. Silva. "An In Silico Analysis of Malaria Pre-Erythrocytic-Stage Antigens Interpreting Worldwide Genetic Data to Suggest Vaccine Candidate Variants and Epitopes." Microorganisms 10, no. 6 (May 25, 2022): 1090. http://dx.doi.org/10.3390/microorganisms10061090.
Повний текст джерелаSong, Xingju, Xu Yang, Taotao Zhang, Jing Liu, and Qun Liu. "A Novel Rhoptry Protein as Candidate Vaccine against Eimeria tenella Infection." Vaccines 8, no. 3 (August 12, 2020): 452. http://dx.doi.org/10.3390/vaccines8030452.
Повний текст джерелаZhao, Ping, Jin-Shan Ke, Zhao-Lin Qin, Hao Ren, Lan-Juan Zhao, Jian-Guo Yu, Jun Gao, Shi-Ying Zhu, and Zhong-Tian Qi. "DNA Vaccine of SARS-Cov S Gene Induces Antibody Response in Mice." Acta Biochimica et Biophysica Sinica 36, no. 1 (January 1, 2004): 37–41. http://dx.doi.org/10.1093/abbs/36.1.37.
Повний текст джерелаVaryushina, Elena A., Georgy V. Alexandrov, Mikhail S. Zakharov, Anna S. Kiryanova, Olga E. Huttunen, Alina B. Rumyantseva, Ilya D. Mitrofanov, et al. "Study of immunogenicity and safety of a candidate rotavirus vaccine based on a recombinant hybrid protein." Medical academic journal 21, no. 2 (September 24, 2021): 87–98. http://dx.doi.org/10.17816/maj71134.
Повний текст джерелаAlshabrmi, Fahad M., Faris Alrumaihi, Sahar Falah Alrasheedi, Wafa Abdullah I. Al-Megrin, Ahmad Almatroudi, and Khaled S. Allemailem. "An In-Silico Investigation to Design a Multi-Epitopes Vaccine against Multi-Drug Resistant Hafnia alvei." Vaccines 10, no. 7 (July 15, 2022): 1127. http://dx.doi.org/10.3390/vaccines10071127.
Повний текст джерелаTsybalova, L. M., L. A. Stepanova, M. A. Shuklina, S. V. Petrov, A. A. Kovaleva, M. V. Potapchuk, A. A. Shaldzhan, Y. A. Zabrodskaya, and V. V. Egorov. "CROSS-PROTECTIVE PROPERTIES OF AN INFLUENZA VACCINE BASED ON HBC4M2E RECOMBINANT PROTEIN." Problems of Virology, Russian journal 63, no. 2 (April 20, 2018): 68–76. http://dx.doi.org/10.18821/0507-4088-2018-63-2-68-76.
Повний текст джерелаWarner, Nikole L., and Kathryn M. Frietze. "Development of Bacteriophage Virus-Like Particle Vaccines Displaying Conserved Epitopes of Dengue Virus Non-Structural Protein 1." Vaccines 9, no. 7 (July 2, 2021): 726. http://dx.doi.org/10.3390/vaccines9070726.
Повний текст джерелаIsmail, Saba, Noorah Alsowayeh, Hyder Wajid Abbasi, Aqel Albutti, Muhammad Tahir ul Qamar, Sajjad Ahmad, Rabail Zehra Raza, Khulah Sadia, and Sumra Wajid Abbasi. "Pan-Genome-Assisted Computational Design of a Multi-Epitopes-Based Vaccine Candidate against Helicobacter cinaedi." International Journal of Environmental Research and Public Health 19, no. 18 (September 14, 2022): 11579. http://dx.doi.org/10.3390/ijerph191811579.
Повний текст джерелаGreen, Bruce A., Ying Zhang, Amy W. Masi, Vicki Barniak, Michael Wetherell, Robert P. Smith, Molakala S. Reddy, and Duzhang Zhu. "PppA, a Surface-Exposed Protein of Streptococcus pneumoniae, Elicits Cross-Reactive Antibodies That Reduce Colonization in a Murine Intranasal Immunization and Challenge Model." Infection and Immunity 73, no. 2 (February 2005): 981–89. http://dx.doi.org/10.1128/iai.73.2.981-989.2005.
Повний текст джерелаRagan, Izabela K., Lindsay M. Hartson, Taru S. Dutt, Andres Obregon-Henao, Rachel M. Maison, Paul Gordy, Amy Fox, et al. "A Whole Virion Vaccine for COVID-19 Produced via a Novel Inactivation Method and Preliminary Demonstration of Efficacy in an Animal Challenge Model." Vaccines 9, no. 4 (April 1, 2021): 340. http://dx.doi.org/10.3390/vaccines9040340.
Повний текст джерелаLiu, Xinsheng, Donghong Zhao, Peng Zhou, Yongguang Zhang, and Yonglu Wang. "Evaluation of the Efficacy of a Recombinant Adenovirus Expressing the Spike Protein of Porcine Epidemic Diarrhea Virus in Pigs." BioMed Research International 2019 (October 8, 2019): 1–8. http://dx.doi.org/10.1155/2019/8530273.
Повний текст джерелаMoezzi, Maryam Sadat, Abdollah Derakhshandeh, and Farhid Hemmatzadeh. "Immunoinformatics analysis of candidate proteins for controlling bovine paratuberculosis." PLOS ONE 17, no. 11 (November 21, 2022): e0277751. http://dx.doi.org/10.1371/journal.pone.0277751.
Повний текст джерелаAnand, S. B., K. N. Kodumudi, M. V. Reddy, and P. Kaliraj. "A combination of two Brugia malayi filarial vaccine candidate antigens (BmALT-2 and BmVAH) enhances immune responses and protection in jirds." Journal of Helminthology 85, no. 4 (January 4, 2011): 442–52. http://dx.doi.org/10.1017/s0022149x10000799.
Повний текст джерелаTang, Tian, Chuan Wang, Qikang Pu, Jinmei Peng, Sijing Liu, Chenyan Ren, Mingjuan Jiang, and Zhijun Tian. "Vaccination of Mice with Listeria ivanovii Expressing the Truncated M Protein of Porcine Reproductive and Respiratory Syndrome Virus Induces both Antigen-Specific CD4+ and CD8+ T Cell-Mediated Immunity." Journal of Molecular Microbiology and Biotechnology 29, no. 1-6 (2019): 74–82. http://dx.doi.org/10.1159/000506686.
Повний текст джерелаLi, Entao, Feihu Yan, Pei Huang, Hang Chi, Shengnan Xu, Guohua Li, Chuanyu Liu, et al. "Characterization of the Immune Response of MERS-CoV Vaccine Candidates Derived from Two Different Vectors in Mice." Viruses 12, no. 1 (January 20, 2020): 125. http://dx.doi.org/10.3390/v12010125.
Повний текст джерелаRoyal, Joshua M., Carrie A. Simpson, Alison A. McCormick, Amanda Phillips, Steve Hume, Josh Morton, John Shepherd, et al. "Development of a SARS-CoV-2 Vaccine Candidate Using Plant-Based Manufacturing and a Tobacco Mosaic Virus-like Nano-Particle." Vaccines 9, no. 11 (November 17, 2021): 1347. http://dx.doi.org/10.3390/vaccines9111347.
Повний текст джерелаChen, Edwin, Nichole D. Salinas, Yining Huang, Francis Ntumngia, Manolo D. Plasencia, Michael L. Gross, John H. Adams, and Niraj Harish Tolia. "Broadly neutralizing epitopes in the Plasmodium vivax vaccine candidate Duffy Binding Protein." Proceedings of the National Academy of Sciences 113, no. 22 (May 18, 2016): 6277–82. http://dx.doi.org/10.1073/pnas.1600488113.
Повний текст джерелаLamazares, Emilio, Fernando Gutiérrez, Angela Hidalgo, Nicolas A. Gutiérrez, Felipe I. Espinoza, Oliberto Sánchez, Marcelo Cortez-San Martín, et al. "A Heterologous Viral Protein Scaffold for Chimeric Antigen Design: An Example PCV2 Virus Vaccine Candidate." Viruses 12, no. 4 (March 31, 2020): 385. http://dx.doi.org/10.3390/v12040385.
Повний текст джерелаBeernink, Peter T., and Dan M. Granoff. "Bactericidal Antibody Responses Induced by Meningococcal Recombinant Chimeric Factor H-Binding Protein Vaccines." Infection and Immunity 76, no. 6 (March 24, 2008): 2568–75. http://dx.doi.org/10.1128/iai.00033-08.
Повний текст джерелаJahantigh, Hamid Reza, Angela Stufano, Farhad Koohpeyma, Vajihe Sadat Nikbin, Zahra Shahosseini, and Piero Lovreglio. "Recombinant GPEHT Fusion Protein Derived from HTLV-1 Proteins with Alum Adjuvant Induces a High Immune Response in Mice." Vaccines 11, no. 1 (January 3, 2023): 115. http://dx.doi.org/10.3390/vaccines11010115.
Повний текст джерела